The secondary composite outcome of death and major disability at 3-month posttreatment follow-up did not differ between treatment groups ( 500 events [ antihypertensive treatment ] vs 502 events [ control ] ; odds ratio , 0.99 [ 95 % CI , 0.86 to 1.15 ] ; P = .93 ) .